Key facts
- Notable investors include Vanderbilt University, DIA (Healthcare).
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for SJC Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for SJC Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SJC Bio
Developer of load-bearing dental bone graft cement designed for quick-setting implant surgeries. The company's product helps with same-day implants that transform patients' dental implant experience while also providing biodegradable bone grafts, enabling healthcare institutions and healthcare professionals to seamlessly provide patients with dental implants.
- Sector
- Healthcare
- HQ
- San Juan Capistrano, CA, United States
- Founded
- 2025
- Ownership
- Privately Held (backing)
SJC Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SJC Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SJC Bio in its N-PORT filings yet. We sweep new filings monthly.